Predictors of relapse in the year after hospital discharge among patients with schizophrenia

Psychiatr Serv. 2012 Jan;63(1):87-90. doi: 10.1176/appi.ps.201100084.

Abstract

Objective: Relapse and its predictors were examined among patients with schizophrenia in the year after hospital discharge.

Methods: The sample included 200 patients with schizophrenia participating in a German multicenter study. Relapse was defined as a worsening of psychopathological symptoms or rehospitalization in the year after hospital discharge. Predictors examined were variables related to course of illness and to response and remission at discharge.

Results: Fifty-two percent of participants had a relapse. Patients whose symptoms were not in remission at discharge were more likely to have a relapse, as were those who had more severe symptoms and more side effects at discharge. Those who experienced a relapse were less likely to be taking a second-generation antipsychotic at discharge, less likely to have a positive attitude toward treatment adherence, and less likely to be employed.

Conclusions: The high rate of relapse among patients with schizophrenia highlights the need to improve current treatment strategies.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Employment / psychology
  • Employment / statistics & numerical data
  • Female
  • Follow-Up Studies
  • Germany
  • Hospitals, Psychiatric
  • Humans
  • Logistic Models
  • Male
  • Medication Adherence / psychology*
  • Middle Aged
  • Patient Discharge
  • Patient Dropouts / psychology
  • Patient Dropouts / statistics & numerical data
  • Patient Readmission / statistics & numerical data
  • Psychiatric Status Rating Scales
  • Recurrence
  • Risk Factors
  • Schizophrenia / drug therapy
  • Schizophrenia / pathology
  • Schizophrenia / rehabilitation*
  • Schizophrenic Psychology*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antipsychotic Agents